147 related articles for article (PubMed ID: 22870446)
1. Bone density, balance and quality of life of postmenopausal women taking alendronate participating in different physical activity programs.
Borba-Pinheiro CJ; de Alencar Carvalho MC; da Silva NS; Drigo AJ; Bezerra JC; Dantas EH
Ther Adv Musculoskelet Dis; 2010 Aug; 2(4):175-85. PubMed ID: 22870446
[TBL] [Abstract][Full Text] [Related]
2. Resistance training programs on bone related variables and functional independence of postmenopausal women in pharmacological treatment: A randomized controlled trial.
Borba-Pinheiro CJ; Dantas EH; Vale RG; Drigo AJ; Carvalho MC; Tonini T; Meza EI; Figueiredo NM
Arch Gerontol Geriatr; 2016; 65():36-44. PubMed ID: 26956618
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
Al-Shoumer KA; Nair V
Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
[TBL] [Abstract][Full Text] [Related]
4. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of predictors of bone mineral density and hip geometry in postmenopausal women: a cross-sectional study.
Singh R; Gupta S; Awasthi A
Arch Osteoporos; 2015; 10():39. PubMed ID: 26556785
[TBL] [Abstract][Full Text] [Related]
6. Effects of alendronate and calcitonin on bone mineral density in postmenopausal osteoporotic women. An observational study.
Hejdova M; Palicka V; Kucera Z; Vlcek J
Pharm World Sci; 2005 Jun; 27(3):149-53. PubMed ID: 16096879
[TBL] [Abstract][Full Text] [Related]
7. Benefit period using alendronate to increase bone mineral density in women with osteoporosis?
Ozdemir F; Rodoplu M
Chin Med J (Engl); 2005 Mar; 118(5):383-90. PubMed ID: 15780207
[TBL] [Abstract][Full Text] [Related]
8. Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis.
Iwamoto J; Takeda T; Sato Y; Uzawa M
Clin Rheumatol; 2004 Oct; 23(5):383-9. PubMed ID: 15278749
[TBL] [Abstract][Full Text] [Related]
9. Benefits of 2 years of intense exercise on bone density, physical fitness, and blood lipids in early postmenopausal osteopenic women: results of the Erlangen Fitness Osteoporosis Prevention Study (EFOPS).
Kemmler W; Lauber D; Weineck J; Hensen J; Kalender W; Engelke K
Arch Intern Med; 2004 May; 164(10):1084-91. PubMed ID: 15159265
[TBL] [Abstract][Full Text] [Related]
10. Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis.
Johnell O; Scheele WH; Lu Y; Reginster JY; Need AG; Seeman E
J Clin Endocrinol Metab; 2002 Mar; 87(3):985-92. PubMed ID: 11889149
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal study on physical fitness parameters influencing bone mineral density reduction in middle-aged and elderly women: bone mineral density in the lumbar spine, femoral neck, and femur.
Iida T; Ikeda H; Shiokawa M; Aoi S; Ishizaki F; Harada T; Ono Y
Hiroshima J Med Sci; 2012 Jun; 61(2):23-8. PubMed ID: 22916509
[TBL] [Abstract][Full Text] [Related]
12. Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate.
Iwamoto J; Takeda T; Sato Y; Uzawa M
Aging Clin Exp Res; 2005 Apr; 17(2):157-63. PubMed ID: 15977465
[TBL] [Abstract][Full Text] [Related]
13. Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis.
Finkelstein JS; Wyland JJ; Lee H; Neer RM
J Clin Endocrinol Metab; 2010 Apr; 95(4):1838-45. PubMed ID: 20164296
[TBL] [Abstract][Full Text] [Related]
14. Factors that contribute to low bone density in postmenopausal women in different amazonian communities.
Borba-Pinheiro CJ; Drigo AJ; de Alencar Carvalho MC; da Silva NS; Dantas EH
Ther Adv Musculoskelet Dis; 2011 Apr; 3(2):81-90. PubMed ID: 22870468
[TBL] [Abstract][Full Text] [Related]
15. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
[TBL] [Abstract][Full Text] [Related]
16. Exercise maintains bone density at spine and hip EFOPS: a 3-year longitudinal study in early postmenopausal women.
Engelke K; Kemmler W; Lauber D; Beeskow C; Pintag R; Kalender WA
Osteoporos Int; 2006 Jan; 17(1):133-42. PubMed ID: 16096715
[TBL] [Abstract][Full Text] [Related]
17. The Relationship of Physical Activity and Anthropometric and Physiological Characteristics to Bone Mineral Density in Postmenopausal Women.
Arazi H; Eghbali E; Saeedi T; Moghadam R
J Clin Densitom; 2016; 19(3):382-8. PubMed ID: 26922458
[TBL] [Abstract][Full Text] [Related]
18. Pre- and postmenopausal bone mineral density of the spine and proximal femur in Japanese women assessed by dual-energy x-ray absorptiometry: a cross-sectional study.
Soda MY; Mizunuma H; Honjo S; Okano H; Ibuki Y; Igarashi M
J Bone Miner Res; 1993 Feb; 8(2):183-9. PubMed ID: 8442436
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study.
Paggiosi MA; Peel N; McCloskey E; Walsh JS; Eastell R
Osteoporos Int; 2014 Dec; 25(12):2729-41. PubMed ID: 25074351
[TBL] [Abstract][Full Text] [Related]
20. [The efficacy of alendronate in the prevention and treatment of postmenopausal osteoporosis].
Cheng ZQ; Yin W; Fan JY; Ma TJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):306-9. PubMed ID: 12905641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
